At present, the key enzymes regulating the ubiquitination of BRD4 in prostate cancer and oral squamous cell carcinoma have been reported, indicating that the downregulation of BRD4 expression abundance by targeting the imbalance of the ubiquitination regulation system can effectively control the development of tumors. Here, BRD4 is linked to prostate carcinoma.